{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:13:14Z","timestamp":1795032794878,"version":"4.10.2"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1097\/cji.0b013e3181587d29","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T04:21:22Z","timestamp":1236226882000},"page":"34-42","source":"Crossref","is-referenced-by-count":42,"title":["CpG Therapy is Superior to BCG in an Orthotopic Bladder Cancer Model and Generates CD4+ T-cell Immunity"],"prefix":"10.1097","volume":"31","author":[{"given":"Sara M.","family":"Mangsbo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Ninalga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Essand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Loskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"T\u00f6tterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210312","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(98)07422-4","article-title":"BCG immunotherapy of bladder cancer: 20 years on","volume":"353","author":"Alexandroff","year":"1999","journal-title":"Lancet"},{"key":"R2-5-20210312","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1067\/mcn.2001.117539","article-title":"Diagnosis and management of superficial bladder cancer","volume":"25","author":"Amling","year":"2001","journal-title":"Curr Probl Cancer"},{"key":"R3-5-20210312","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00262-004-0621-x","article-title":"Immunotherapy for superficial bladder cancer","volume":"54","author":"Schenk-Braat","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"R4-5-20210312","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0192-0561(92)90075-V","article-title":"Changes of host cell infiltration into Meth A fibrosarcoma tumor during the course of regression induced by injections of a BCG nucleic acid fraction","volume":"14","author":"Kuramoto","year":"1992","journal-title":"Int J Immunopharmacol"},{"key":"R5-5-20210312","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"key":"R6-5-20210312","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0168-9525(87)90294-0","article-title":"CpG islands as gene markers in the vertebrate nucleus","volume":"3","author":"Bird","year":"1995","journal-title":"Trends Genet"},{"key":"R7-5-20210312","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.167.7.3555","article-title":"Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells","volume":"167","author":"Takeshita","year":"2001","journal-title":"J Immunol"},{"key":"R8-5-20210312","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"R9-5-20210312","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/eji.200323813","article-title":"Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells","volume":"33","author":"Hartmann","year":"2003","journal-title":"Eur J Immunol"},{"key":"R10-5-20210312","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00002371-200501000-00003","article-title":"CpG oligonucleotide therapy cures subcutaneous and orthotopic tumors and evokes protective immunity in murine bladder cancer","volume":"28","author":"Ninalga","year":"2005","journal-title":"J Immunother"},{"key":"R11-5-20210312","first-page":"2225","article-title":"Antineoplastic effect of immunostimulatory DNA (CpG-ODN) in a murine C57-BL6\/MB-49 transitional cell carcinoma model","volume":"24","author":"Hegele","year":"2004","journal-title":"Anticancer Res"},{"key":"R12-5-20210312","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000087380","article-title":"Immunostimulatory CpG oligonucleotides reduce tumor burden after intravesical administration in an orthotopic murine bladder cancer model","volume":"26","author":"Hegele","year":"2005","journal-title":"Tumour Biol"},{"key":"R13-5-20210312","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0022-5347(17)35678-1","article-title":"T-cell subsets required for intravesical BCG immunotherapy for bladder cancer","volume":"150","author":"Ratliff","year":"1993","journal-title":"J Urol"},{"key":"R14-5-20210312","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cyto.2005.07.009","article-title":"Cytometric bead array (CBA) for the measurement of cytokines in urine and plasma of patients undergoing renal rejection","volume":"32","author":"Jimenez","year":"2005","journal-title":"Cytokine"},{"key":"R15-5-20210312","doi-asserted-by":"crossref","first-page":"7200","DOI":"10.4049\/jimmunol.172.11.7200","article-title":"Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor microenvironment","volume":"172","author":"Loskog","year":"2004","journal-title":"J Immunol"},{"key":"R16-5-20210312","first-page":"6956","article-title":"Intratumoral vaccination with vaccinia-expressed tumor antigen and granulocyte macrophage colony-stimulating factor overcomes immunological ignorance to tumor antigen","volume":"63","author":"Yang","year":"2003","journal-title":"Cancer Res"},{"key":"R17-5-20210312","first-page":"2150","article-title":"Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses","volume":"63","author":"Yang","year":"2003","journal-title":"Cancer Res"},{"key":"R18-5-20210312","first-page":"911","article-title":"Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site","volume":"59","author":"Halak","year":"1999","journal-title":"Cancer Res"},{"key":"R19-5-20210312","doi-asserted-by":"crossref","first-page":"8816","DOI":"10.1158\/1078-0432.CCR-05-1817","article-title":"AdCD40L gene therapy counteracts T regulatory cells and cures aggressive tumors in an orthotopic bladder cancer model","volume":"11","author":"Loskog","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R20-5-20210312","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0022-5347(05)65928-9","article-title":"Potent antitumor effects of CD154 transduced tumor cells in experimental bladder cancer","volume":"166","author":"Loskog","year":"2001","journal-title":"J Urol"},{"key":"R21-5-20210312","first-page":"2834","article-title":"Optimizing syngeneic orthotopic murine bladder cancer (MB49)","volume":"59","author":"Gunther","year":"1999","journal-title":"Cancer Res"},{"key":"R22-5-20210312","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/1097-0215(20010601)92:5<697::AID-IJC1245>3.0.CO;2-Z","article-title":"NK cells are essential for effective BCG immunotherapy","volume":"92","author":"Brandau","year":"2001","journal-title":"Int J Cancer"},{"key":"R23-5-20210312","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"R24-5-20210312","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1086\/314063","article-title":"Immunology of bacille Calmette-Guerin and related topics","volume":"31","author":"Wittes","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R25-5-20210312","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1158\/0008-5472.CAN-06-1416","article-title":"Neutrophil granulocytes are required for effective bacillus Calmette-Guerin immunotherapy of bladder cancer and orchestrate local immune responses","volume":"66","author":"Suttmann","year":"2006","journal-title":"Cancer Res"},{"key":"R26-5-20210312","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2567.2006.02517.x","article-title":"Macrophages are essential for antitumour effects against weakly immunogenic murine tumours induced by class B CpG-oligodeoxynucleotides","volume":"120","author":"Buhtoiarov","year":"2007","journal-title":"Immunology"},{"key":"R27-5-20210312","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.4049\/jimmunol.171.8.3941","article-title":"Intratumor CpG-oligodeoxynucleotide injection induces protective antitumor T cell immunity","volume":"171","author":"Lonsdorf","year":"2003","journal-title":"J Immunol"},{"key":"R28-5-20210312","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.4049\/jimmunol.172.10.6065","article-title":"Toll-like receptor ligands directly promote activated CD4+ T cell survival","volume":"172","author":"Gelman","year":"2004","journal-title":"J Immunol"},{"key":"R29-5-20210312","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.coi.2005.03.003","article-title":"Signaling in B cells via Toll-like receptors","volume":"17","author":"Peng","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"R30-5-20210312","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.4049\/jimmunol.177.4.2373","article-title":"Distinct responses of lung and spleen dendritic cells to the TLR9 agonist CpG oligodeoxynucleotide","volume":"177","author":"Chen","year":"2006","journal-title":"J Immunol"},{"key":"R31-5-20210312","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2249.2006.03191.x","article-title":"Role of Th1-stimulating cytokines in bacillus Calmette-Guerin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells","volume":"146","author":"Luo","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"R32-5-20210312","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.4049\/jimmunol.167.9.5247","article-title":"NK- and CD8(+) T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides","volume":"167","author":"Kawarada","year":"2001","journal-title":"J Immunol"},{"key":"R33-5-20210312","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1002\/1521-4141(200012)30:12<3591::AID-IMMU3591>3.0.CO;2-J","article-title":"Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins","volume":"30","author":"Sparwasser","year":"2000","journal-title":"Eur J Immunol"},{"key":"R34-5-20210312","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.4049\/jimmunol.168.12.6099","article-title":"Vaccination with tumor peptide in CpG adjuvant protects via IFN-gamma-dependent CD4 cell immunity","volume":"168","author":"Stern","year":"2002","journal-title":"J Immunol"},{"key":"R35-5-20210312","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0092-8674(01)00237-9","article-title":"The TNF and TNF receptor superfamilies: integrating mammalian biology","volume":"104","author":"Locksley","year":"2001","journal-title":"Cell"},{"key":"R36-5-20210312","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25\u2212 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"key":"R37-5-20210312","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/intimm\/dxh126","article-title":"TGFbeta regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo","volume":"16","author":"Schramm","year":"2004","journal-title":"Int Immunol"},{"key":"R38-5-20210312","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/intimm\/dxl136","article-title":"TLR9 ligand enhances proliferation of rat CD4+ T cell and modulates suppressive activity mediated by CD4+ CD25+ T cell","volume":"19","author":"Chiffoleau","year":"2007","journal-title":"Int Immunol"},{"key":"R39-5-20210312","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.juro.2006.08.078","article-title":"Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines","volume":"177","author":"Loskog","year":"2007","journal-title":"J Urol"}],"container-title":["Journal of Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CJI.0b013e3181587d29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:01:54Z","timestamp":1621886514000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002371-200801000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/cji.0b013e3181587d29","relation":{},"ISSN":["1524-9557"],"issn-type":[{"value":"1524-9557","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}